By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014 9:28:38 AM
AVANIR Pharmaceuticals (AVNR) Announces Initiation Of Phase 2 Study Of AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder 8/26/2014 7:32:22 AM
AVANIR Pharmaceuticals (AVNR) Reports Fiscal 2014 Third Quarter Financial And Business Update 8/6/2014 8:01:44 AM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In August 8/5/2014 9:11:16 AM
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Third Quarter Financial Results And Conference Call 7/28/2014 8:50:47 AM
AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder 7/21/2014 12:38:42 PM
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of Positive Early Results From Prism II Study 7/16/2014 9:54:16 AM
AVANIR Pharmaceuticals (AVNR) Announces Two Data Presentations Related To Pseudobulbar Affect (PBA) At The Alzheimer's Association International Conference (AAIC) 7/1/2014 9:53:34 AM
AVANIR Pharmaceuticals (AVNR) Announces Three Data Presentations Related To AVP-825 For The Acute Treatment Of Migraine At The American Headache Society Annual Meeting 6/24/2014 7:17:19 AM
AVANIR Pharmaceuticals (AVNR)' Migraine Drug AVP-825 Meets Primary Endpoint in Phase 3 Trial 6/10/2014 6:29:28 AM